Business Context and Reporting Period
Company: Champions Oncology, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: July 23, 2025
Subject: Announcement of audited financial results for the fiscal year ended April 30, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification that the results have been issued via a press release (Exhibit 99.1), but the numerical data is not included in the body of this report.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The report explicitly states that the information under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 23, 2025) for actual financial figures.
- Verify the audited financial statements for the fiscal year ended April 30, 2025, in the Company's subsequent 10-K filing.
- Confirm the Company's status as an emerging growth company (indicated as "no" in this filing).